Decrease in risks as compared to other methods can foster the growth of the Global Jet Injector Market

Published: Mar 2021

The jet injector market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The market growth is mainly attributed to the decrease in risks such as contamination and needle stick injuries during injections. The importance of jet injector is increasing across the globe as it is a pain-free injector and does not damage the skin. Whereas the needle type injectors may lead to infections such as Hepatitis C and Hepatitis B as well as skin damage if used in the wrong way. Old age people have low immune systems and cannot easily bear the pain caused by the needle-type injectors. This is one of the key driving factors due to the increasing aging population globally. The increase in demand for self-injection devices, technological advancement, growing expenditure for healthcare facilities by the government is some of the other factors that are expected to fuel the market growth in the forecast period.

Browse the full report description of "Global Jet Injector Market Size, Share & Trends Analysis Report by Product (Prefilled Needle-Free Injectors and Fillable Needle-Free Injectors), By Application (Insulin Delivery, Respiratory Delivery, Vaccine Delivery, and Others), By Technology (Jet Based, Spring Based, Laser Power Based and Vibration Based), By End-User (Pharmaceutical Companies, Hospital & Clinical Centres and Others) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/jet-injector-market

Significant activities in the field of the jet injector market have been witnessed globally. For instance, in December 2019, LEO Pharma A/S and Portal Instruments announced their collaboration to develop Portal’s needle-free drug delivery system to use with LEO Pharma’s approved medicines. Moreover, in February 2021, Altimmune, Inc., a clinical-stage biopharmaceutical company commenced the enrollment in Phase 1 clinical trial of AdCOVID, a needle-free single-dose intranasal COVID-19 vaccine candidate. 

Market Coverage

  • The market number available for – 2019-2026
  • Base year- 2019
  • Forecast period- 2020-2026
  • Segment Covered- 

o By Product Type

o By Application

o By Technology

o By End-User

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Crossject SA, PharmaJet, European Pharma Group BV, Merck KGaA, Becton, Dickinson, and Co.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Jet Injector Market Report Segment

By Product 

  • Prefilled Needle-Free Injectors
  • Fillable Needle-Free Injectors

By Application 

  • Insulin Delivery
  • Respiratory Diseases
  • Vaccine Delivery
  • Others

By Technology 

  • Jet Based
  • Spring Based
  • Laser Power Based
  • Vibration-Based

By End-User

  • Pharmaceutical Companies
  • Hospital & Clinical Centres
  • Others

Global Jet Injector Report Segment by Region

North America           

  • US
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa 
  • Latin America 

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/jet-injector-market